Global Information
회사소개 | 문의 | 비교리스트

세계의 양수천자침 시장 : 바늘 종류별, 시술 종류별, 최종사용자별, 지역별 - 성장, 동향, 예측(2018-2023년)

Amniocentesis Needle Market - Growth, Trends, and Forecast (2020 - 2025)

리서치사 Mordor Intelligence LLP
발행일 2020년 02월 상품 코드 661181
페이지 정보 영문
가격
US $ 4,250 ₩ 5,209,000 PDF by E-mail (Single User License)
US $ 4,750 ₩ 5,822,000 PDF by E-mail (Team License: Up to 7 Users)
US $ 6,000 ₩ 7,354,000 PDF by E-mail (Site License)
US $ 7,500 ₩ 9,192,000 PDF by E-mail (Corporate License)


세계의 양수천자침 시장 : 바늘 종류별, 시술 종류별, 최종사용자별, 지역별 - 성장, 동향, 예측(2018-2023년) Amniocentesis Needle Market - Growth, Trends, and Forecast (2020 - 2025)
발행일 : 2020년 02월 페이지 정보 : 영문

세계 양수천자침 시장의 2018-2023년 연평균 성장률(CAGR)은 약 5.4%로 전망됩니다. 양수검사는 임신 중기에 양수천자침을 이용해 태아 주변의 양수를 채취해 태아의 이상을 진단하기 위해서 행해집니다.

세계의 양수천자침(Amniocentesis Needle) 시장에 대해 조사했으며, 시장 개요, 바늘 종류·시술 종류·최종사용자·지역별 시장 규모 추정과 예측, 시장 동향, 성장 촉진요인·저해요인 및 시장 기회·과제 분석, 경쟁 상황, 주요 기업 개요 등의 정보를 전해드립니다.

목차

제1장 서론

  • 시장 정의

제2장 조사 방법

제3장 주요 요약

제4장 주요 영향요인

제5장 시장 개요

  • 현재 시장 시나리오
  • Porter's Five Forces 분석
    • 구매자의 협상력
    • 공급 기업의 협상력
    • 신규 참여업체의 위협
    • 대체품의 위협
    • 경쟁 기업간 경쟁 관계

제6장 성장 촉진요인, 성장 저해요인, 시장 기회, 과제

  • 성장 촉진요인
    • 양수 검사의 높은 신뢰성
    • 초산 연령의 중앙치 상승
    • 선천성 질환의 부담
  • 성장 저해요인
    • 대체법의 이용 가능성
  • 시장 기회
  • 주요 과제

제7장 시장 세분화

  • 바늘 종류별
    • 100mm-150mm
    • 151mm 이상
    • 99mm 이하
  • 시술 종류별
    • 양수천자
    • 양수감압
    • 태아수혈
    • 양수주입
    • 탯줄천자
  • 최종사용자별
    • 병원
    • 진단 센터
    • 진료소
    • 기타
  • 지역별
    • 북미
    • 유럽
    • 아시아태평양
    • 기타 지역

제8장 경쟁 상황

  • M&A 분석
  • 합의, 협업, 파트너십
  • 신제품 발매

제9장 주요 기업

  • Becton, Dickinson and Company
  • Biopsybell
  • Cook Medical
  • Coopersurgical
  • Integra Lifesciences
  • Laboratoire Ccd
  • Medline
  • Medtronic
  • Ri.Mos.
  • Rocket Medical
  • Smiths Medical
  • Tsunami Medical

제10장 시장의 향후 전망

KSM 18.07.23

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

The market for Amniocentesis is expected to grow during the forecast period. Certain factors that are responsible for the growth of this market are the growing median age of first-time motherhood, the increasing burden of the congenital diseases, and the high reliability of people on amniocentesis.

Amniocentesis is almost 99.4% accurate and this test determines if the baby in the womb has any genetic or chromosomal abnormalities. The test can identify many genetic disorders, such as Down syndrome, Edward's syndrome, Tay-Sachs disease, Huntington's disease, Sickle cell disease, and cystic fibrosis. It can provide the information needed to diagnosis these complications in the fetus. Due to the high reliability of the test, the market is expected to expand during the forecast period.

Key Market Trends

Amniocentesis Procedure is Expected to Show Steady Growth Over the Forecast Period

According to the American Association for Clinical Chemistry, it has been observed that more than 20,000 amniocentesis procedures are performed in the United States alone every year. Rising concern about genetic disorders is the major factor responsible for the growing number of procedures. The use of amniocentesis is done since 1970. Majorly, it is being used for prenatal diagnosis of genetic disease and neural tube defects.

Various studies have been conducted by organizations such as the National Institute of Health (NIH) to understand the risks associated with amniocentesis procedure and the challenges during the same. Studies have revealed that the occurrence of early abortion after amniocentesis is a major risk and around its prevalence is around 10%. However, due to the technical advancements in the needles and the focus of medical professionals on the safety of the patient, it is expected that the chances of early abortions will be reduced in the near future.

Therefore, due to the rising number of amniocentesis procedures, growing adoption of the same and increasing focus on patient safety, the amniocentesis procedure segment is expected to show steady growth over the forecast period.

North America to Maintain Lead in the Amniocentesis Market

The global amniocentesis needle market is dominated by North America and Europe respectively. North America will continue to dominate the global market during the forecast period. Factors, such as the rising government initiatives and an increasing number of amniocentesis procedures, are driving the growth of the market in this region.

The developed healthcare system in the United States is augmenting the demand for advanced products which is accelerating the growth of amniocentesis needles with advanced technology. Added to that, a concern of the general population in North America region about the genetic disorders in a newborn is propelling the demand for amniocentesis procedure.

Competitive Landscape

The market for amniocentesis needles is moderately competitive and is comprised mostly of local companies. Countries like China and India are having a large number of local suppliers for the amniocentesis needles which is posing an intense competition among these local companies. The market is also witnessing the presence of global companies but the competition among the big players is comparatively lower than that of the local players.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 High Reliability of Amniocentesis
    • 4.2.2 Growing Median Age of First-Time Motherhood
    • 4.2.3 Increasing Burden of Congenital Disorders
  • 4.3 Market Restraints
    • 4.3.1 Availability of Alternate Methods
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Type
    • 5.1.1 100 to 150 mm Needles
    • 5.1.2 Larger Than 150 mm Needles
    • 5.1.3 Smaller Than 100 mm Needles
  • 5.2 By Procedure
    • 5.2.1 Amniocentesis Procedures
    • 5.2.2 Amnioreduction Procedures
    • 5.2.3 Fetal Blood Transfusion Procedures
    • 5.2.4 Amnioinfusion Procedures
    • 5.2.5 Cordocentesis Procedures
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 US
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 UK
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 The Ccoper Companis Inc.
    • 6.1.2 Becton, Dickinson and Company
    • 6.1.3 Cook Medical Incorporated
    • 6.1.4 RI.MOS. Srl
    • 6.1.5 Tsunami Medical
    • 6.1.6 Smiths Medical
    • 6.1.7 Laboratoire Ccd
    • 6.1.8 Integra Lifesciences
    • 6.1.9 Medtronic Plc
    • 6.1.10 Medline Industries Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top
전화 문의
F A Q